| Up-down regulation of HIF-1α in cancer progression M Rashid, LR Zadeh, B Baradaran, O Molavi, Z Ghesmati, M Sabzichi, ... Gene 798, 145796, 2021 | 162 | 2021 |
| Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells A Minaei, M Sabzichi, F Ramezani, H Hamishehkar, N Samadi Molecular biology reports 43, 99-105, 2016 | 124 | 2016 |
| Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling M Sabzichi, H Hamishehkar, F Ramezani, S Sharifi, M Tabasinezhad, ... Asian Pacific Journal of Cancer Prevention 15 (13), 5311-5316, 2014 | 124 | 2014 |
| Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment M Sabzichi, N Samadi, J Mohammadian, H Hamishehkar, M Akbarzadeh, ... Colloids and Surfaces B: Biointerfaces 145, 64-71, 2016 | 95 | 2016 |
| Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer A Tupal, M Sabzichi, F Ramezani, M Kouhsoltani, H Hamishehkar Journal of microencapsulation 33 (4), 372-380, 2016 | 90 | 2016 |
| Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells S Mahmoudi, M Ghorbani, M Sabzichi, F Ramezani, H Hamishehkar, ... Journal of Drug Delivery Science and Technology 49, 268-276, 2019 | 72 | 2019 |
| Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism NF Maroufi, V Vahedian, SAM Mazrakhondi, W Kooti, HA Khiavy, ... Naunyn-Schmiedeberg's Archives of Pharmacology 393, 1-11, 2020 | 69 | 2020 |
| Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line S Raeisi, H Chavoshi, M Mohammadi, M Ghorbani, M Sabzichi, ... Process Biochemistry 83, 168-175, 2019 | 60 | 2019 |
| Vitamin D-loaded nanostructured lipid carrier (NLC): a new strategy for enhancing efficacy of doxorubicin in breast cancer treatment M Sabzichi, J Mohammadian, M Mohammadi, F Jahanfar, ... Nutrition and cancer 69 (6), 840-848, 2017 | 42 | 2017 |
| Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways MB Pirouzpanah, M Sabzichi, S Pirouzpanah, H Chavoshi, N Samadi Asian Pacific journal of cancer prevention 16 (5), 2087-2092, 2015 | 42 | 2015 |
| Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway M Sabzichi, J Mohammadian, R Bazzaz, MB Pirouzpanah, M Shaaker, ... Process biochemistry 60, 84-91, 2017 | 40 | 2017 |
| The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line M Armat, TO Bakhshaiesh, M Sabzichi, D Shanehbandi, S Sharifi, ... Bosnian journal of basic medical sciences 16 (1), 28, 2016 | 40 | 2016 |
| Combined treatment with stattic and docetaxel alters the Bax/Bcl-2 gene expression ratio in human prostate cancer cells J Mohammadian, M Sabzichi, O Molavi, D Shanehbandi, N Samadi Asian Pacific journal of cancer prevention: APJCP 17 (11), 5031, 2016 | 40 | 2016 |
| Fabrication of all-trans-retinoic acid-loaded biocompatible precirol: A strategy for escaping dose-dependent side effects of doxorubicin M Sabzichi, J Mohammadian, M Ghorbani, S Saghaei, H Chavoshi, ... Colloids and Surfaces B: Biointerfaces 159, 620-628, 2017 | 38 | 2017 |
| The synergistic impact of quinacrine on cell cycle and anti-invasiveness behaviors of doxorubicin in MDA-MB-231 breast cancer cells M Sabzichi, M Ramezani, J Mohammadian, M Ghorbani, A Mardomi, ... Process Biochemistry 81, 175-181, 2019 | 27 | 2019 |
| Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis M Ghorbani, M Sabzichi, F Ramezani, J Mohammadian Biomedicine & Pharmacotherapy 109, 1240-1248, 2019 | 27 | 2019 |
| Folate-targeted nanostructured lipid carriers (NLCs) enhance (Letrozol) efficacy in MCF-7 breast cancer cells M Sabzichi, J Mohammadian, AY Khosroushahi, R Bazzaz, ... Asian Pacific journal of cancer prevention: APJCP 17 (12), 5185, 2016 | 23 | 2016 |
| Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells J Mohammadian, S Mahmoudi, P Pourmohammad, M Pirouzpanah, ... Naunyn-Schmiedeberg's Archives of Pharmacology 393, 2315-2323, 2020 | 22 | 2020 |
| Six Family of Homeobox Genes and Related Mechanisms in Tumorigenesis Protocols M Armat, F Ramezani, O Molavi, M Sabzichi, N Samadi Tumori Journal 102 (3), 236-243, 2016 | 22 | 2016 |
| Application of ɑ-tocotrienol-loaded biocompatible precirol in attenuation of doxorubicin dose-dependent behavior in HUH-7 hepatocarcinoma cell line A Tupal, M Sabzichi, R Bazzaz, N Fathi Maroufi, M Mohammadi, ... Nutrition and Cancer 72 (4), 653-661, 2020 | 21 | 2020 |
Murphy Lam-Yim WanSenior Lecturer, School of Pharmacy and Biomedical Sciences, University of Portsmouth在 port.ac.uk 的电子邮件经过验证
